Reactive Biosciences of Durham (formerly Boragen) disclosed in an SEC filing that it has raised $4 million in debt. The company last raised more than $23 million in equity funding in the fall of 2022.
[Report of 213 Pages] By the end of 2029, the market for canine atopic dermatitis treatment is anticipated to reach more than US$ 2.37 billion. The market is anticipated to grow as more emphasis is placed on the creation of novel therapeutics like monoclonal antibodies for the treatment of atopic dermatitis in dogs.
2022 Space Awards winners: Top development projects in Raleigh, Durham region bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
A partnership between North Carolina analytics leader SAS and life sciences capital firm Pappas Capital is staged to help the state become a global leader in agricultural technology.